FDA Finalizes Guidance on Device Manufacturing Discontinuance Notifications
January 07, 2025
January 07, 2025
WASHINGTON, Jan. 7 (TNSFR) -- The Food and Drug Administration (FDA) has announced the availability of its final guidance regarding the notification process for the permanent discontinuance or interruption in the manufacturing of medical devices under Section 506J of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
This updated guidance, published on January 7, 2025, builds upon the previously issued version from November 2023, alongside finalizing a set of updates related t . . .
This updated guidance, published on January 7, 2025, builds upon the previously issued version from November 2023, alongside finalizing a set of updates related t . . .